Abstract
Studies performed on chimpanzees and humans have revealed that strong, multispecific and sustained CD4+ and CD8+ T cell immune responses is a major determinant of hepatitis C virus (HCV) clearance. However, spontaneous elimination of the virus occurs in minority of infected individuals and cellular response directed against HCV antigens is not persistent in individuals with chronic infection. This review presents characteristics of the HCV-specific T cell response in patients with different clinical course of infection, including acute and chronic infection, persons who spontaneously eliminated HCV and non-infected subjects exposed to HCV. Detection of HCV-specific response, especially in non-infected subjects exposed to HCV, may be indicative of HCV prevalence in population and rate of spontaneous viral clearance. Understanding the mechanisms and role of HCV-specific cellular immune response would contribute to better understanding of HCV epidemiology, immunopathogenesis and may help to design an effective vaccine.
Similar content being viewed by others
Abbreviations
- Bcl-2:
-
B-cell lymphoma 2
- DCs:
-
Dendritic cells
- HCV:
-
Hepatitis C virus
- HCV:
-
RNA hepatitis C viral genetic material
- HLA-DR:
-
Human leukocyte antigen D related
- PWIDs:
-
People who inject drugs
- IFN-γ:
-
Interferon γ
- IL-2:
-
Interleukin 2
- Th1:
-
T helper cells
- TNF:
-
Tumor necrosis factor
References
Aberle JH, Formann E, Steindl-Munda P et al (2006) Prospective study of viral clearance and CD4(+) T-cell response in acute hepatitis C primary infection and reinfection. J Clin Virol 36:24–31
Aberle JH, Perstinger G, Weseslindtner L et al (2007) CD4+ T cell responses in patients with chronic hepatitis C undergoing peginterferon/ribavirin therapy correlate with faster, but not sustained, viral clearance. J Infect Dis 195:1315–1319
Al-Sherbiny M, Osman A, Mohamed N et al (2005) Exposure to hepatitis C virus induces cellular immune responses without detectable viremia or seroconversion. Am J Trop Med Hyg 73:44–49
Appay V, Dunbar PR, Callan M et al (2002) Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 8:379–385
Arrojo IP, Pareja MO, Orta MD et al (2003) Detection of a healthy carrier of HCV with no evidence of antibodies for over four years. Transfusion 43:953–957
Badr G, Bédard N, Abdel-Hakeem MS et al (2008) Early interferon therapy for hepatitis C virus infection rescues polyfunctional, long-lived CD8+ memory T cells. J Virol 82:10017–10031
Bain C, Fatmi A, Zoulim F et al (2001) Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 120:512–524
Barnes E, Harcourt G, Brown D et al (2002) The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection. Hepatology 36:743–754
Bassett SE, Guerra B, Brasky K et al (2001) Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection. Hepatology 33:1479–1487
Bjoro K, Froland SS, Yun Z et al (1994) Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med 331:1607–1611
Boettler T, Spangenberg HC, Neumann-Haefelin C et al (2005) T cells with a CD4+ CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 79:7860–7867
Bolacchi F, Sinistro A, Ciaprini C et al (2006) Increased hepatitis C virus (HCV)-specific CD4+ CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels. Clin Exp Immunol 144:188–196
Bronowicki JP, Vetter D, Uhl G et al (1997) Lymphocyte reactivity to hepatitis C virus (HCV) antigens shows evidence for exposure to HCV in HCV-seronegative spouses of HCV-infected patients. J Infect Dis 176:518–522
Carreno V (2006) Occult hepatitis C virus infection: a new form of hepatitis C. World J Gastroenterol 12:6922–6925
Carreno V, Bartolome J, Castillo I et al (2012) New perspectives in occult hepatitis C virus infection. World J Gastroenterol 18:2887–2894
Castillo I, Pardo M, Bartolomé J et al (2004) Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis 189:7–14
Chang KM, Thimme R, Melpolder JJ et al (2001) Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection. Hepatology 33:267–276
Chapel HM, Christie JM, Peach V et al (2001) Five-year follow-up of patients with primary antibody deficiencies following an outbreak of acute hepatitis C. Clin Immunol 99:320–324
Cooper Erickson AL, Adams EJ et al (1999) Analysis of a successful immune response against hepatitis C virus. Immunity 10:439–449
Cox AL, Mosbruger T, Mao Q et al (2005) Cellular immune selection with hepatitis C virus persistence in humans. J Exp Med 201:1741–1752
Cramp ME, Carucci P, Rossol S et al (1999) Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia. Gut 44:424–429
Day CL, Lauer GM, Robbins GK et al (2002) Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. J Virol 76:12584–12595
Della Bella S, Riva A, Tanzi E et al (2005) Hepatitis C virus-specific reactivity of CD4+ -lymphocytes in children born from HCV-infected women. J Hepatol 43:394–402
Elliot LN, Lloyd AR, Ziegler JB et al (2006) Protective immunity against hepatitis C virus infection. Immunol Cell Biol 84:239–249
Erickson AL, Kimura Y, Igarashi S et al (2001) The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity 15:883–895
Farci P, Alter HJ, Govindarajan S et al (1992) Lack of protective immunity against reinfection with hepatitis C virus. Science 258:135–140
Freeman AJ, Pan Y, Harvey CE et al (2003) The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection. J Hepatol 38:349–356
Freeman AJ, Marinos G, Ffrench RA et al (2005) Intrahepatic and peripheral blood virus-specific cytotoxic T lymphocyte activity is associated with a response to combination IFN-alpha and ribavirin treatment among patients with chronic hepatitis C virus infection. J Viral Hepat 12:125–129
Grakoui A, Shoukry NH, Woollard DJ et al (2003) HCV persistence and immune evasion in the absence of memory T cell help. Science 302:659–662
Grebely J, Conway B, Raffa JD et al (2006) Hepatitis C virus reinfection in injection drug users. Hepatology 44:1139–1145
Groux H, Bigler M, de Vries JE et al (1996) Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med 184:19–29
Groux H, O’Garra A, Bigler M et al (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737–742
Gruner NH, Gerlach TJ, Jung MC et al (2000) Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. J Infect Dis 181:1528–1536
Guidotti LG, Chisari FV (2001) Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 19:65–91
Harcourt G, Hellier S, Bunce M et al (2001) Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection. J Viral Hepat 8:174–179
Hashem M, El-Karaksy H, Shata MT et al (2011) Strong hepatitis C virus (HCV)-specific cell-mediated immune responses in the absence of viremia or antibodies among uninfected siblings of HCV chronically infected children. J Infect Dis 203:854–861
He XS, Rehermann B, López-Labrador FX et al (1999) Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci USA 96:5692–5697
Houghton M, Abrignani S (2005) Prospects for a vaccine against the hepatitis C virus. Nature 436:961–966
Kamal SM, Fehr J, Roesler B et al (2002) Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C. Gastroenterology 123:1070–1083
Kamal SM, Amin A, Madwar M et al (2004) Cellular immune responses in seronegative sexual contacts of acute hepatitis C patients. J Virol 78:12252–12258
Kantzanou M, Lucas M, Barnes E et al (2003) Viral escape and T cell exhaustion in hepatitis C virus infection analysed using Class I peptide tetramers. Immunol Lett 85:165–171
Kennedy PT, Urbani S, Moses RA et al (2006) The influence of T cell cross-reactivity on HCV-peptide specific human T cell response. Hepatology 43:602–611
Koziel MJ, Wong DK, Dudley D et al (1997) Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons. J Infect Dis 176:859–866
Kuntzen T, Timm J, Berical A et al (2007) Viral sequence evolution in acute hepatitis C virus infection. J Virol 81:11658–11668
Lafarge S, Hamzeh-Cognasse H, Chavarin P et al (2007) A flow cytometry technique to study intracellular signals NF-kappaB and STAT3 in peripheral blood mononuclear cells. BMC Mol Biol 8:64
Lai ME, Mazzoleni AP, Argiolu F et al (1994) Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 343:388–390
Lauer GM, Walker BD (2001) Hepatitis C virus infection. N Engl J Med 345:41–52
Lauer GM, Barnes E, Lucas M et al (2004) High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology 127:924–936
Lechner F, Wong DK, Dunbar PR et al (2000) Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191:1499–1512
Lucas M, Ulsenheimer A, Pfafferot K et al (2007) Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infection. PLoS One 2:e649
MacDonald AJ, Duffy M, Brady MT et al (2002) CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. J Infect Dis 185:720–727
Maheshwari A, Ray S, Thuluvath PJ (2008) Acute hepatitis C. Lancet 372:321–332
Major ME, Mihalik K, Puig M et al (2002) Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge. J Virol 76:6586–6595
Martin B, Hennecke N, Lohmann V et al (2014) Restoration of HCV-specific CD8+ T cell function by interferon-free therapy. J Hepatol 61:538–543
McKiernan SM, Hagan R, Curry M et al (2004) Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source. Hepatology 40:108–114
Mehta SH, Cox A, Hoover DR et al (2002) Protection against persistence of hepatitis C. Lancet 359:1478–1483
Minton EJ, Smillie D, Neal KR et al (1998) Association between MHC class II alleles and clearance of circulating hepatitis C virus. Members of the Trent Hepatitis C Virus Study Group. J Infect Dis 178:39–44
Minutello MA, Pileri P, Unutmaz D et al (1993) Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med 178:17–25
Neumann-Haefelin C, Blum HE, Chisari FV et al (2005) T cell response in hepatitis C virus infection. J Clin Virol 32:75–85
Neumann-Haefelin C, McKiernan S, Ward S et al (2006) Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution. Hepatology 43:563–572
Neumann-Haefelin C, Spangenberg HC, Blum HE et al (2007) Host and viral factors contributing to CD8+ T cell failure in hepatitis C virus infection. World J Gastroenterol 13:4839–4847
Page K, Hahn JA, Evans J et al (2009) Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. J Infect Dis 200:1216–1226
Penna A, Pilli M, Zerbini A et al (2007) Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection. Hepatology 45:588–601
Pilli M, Zerbini A, Penna A et al (2007) HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project). Gastroenterology 133:1132–1143
Post JJ, Pan Y, Freeman AJ et al (2004) Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort. J Infect Dis 189:1846–1855
Prince AM, Brotman B, Huima T et al (1992) Immunity in hepatitis C infection. J Infect Dis 165:438–443
Prlic M, Lefrancois L, Jameson SC (2002) Multiple choices: regulation of memory CD8 T cell generation and homeostasis by interleukin (IL)-7 and IL-15. J Exp Med 195:F49–F52
Quiroga JA, Llorente S, Castillo I et al (2006) Cellular immune responses associated with occult hepatitis C virus infection of the liver. J Virol 80:10972–10979
Radziewicz H, Ibegbu CC, Fernandez ML et al (2007) Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J Virol 81:2545–2553
Razvi S, Schneider L, Jonas MM et al (2001) Outcome of intravenous immunoglobulin-transmitted hepatitis C virus infection in primary immunodeficiency. Clin Immunol 101:284–288
Riviere Y, Montange T, Janvier G et al (2012) Hepatitis C virus-specific cellular immune responses in individuals with no evidence of infection. Virol J 9:76
Rosen HR, Miner C, Sasaki AW et al (2002) Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages. Hepatology 35:190–198
Rushbrook SM, Ward SM, Unitt E et al (2005) Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection. J Virol 79:7852–7859
Sarobe P, Lasarte JJ, Casares N et al (2002) Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins. J Virol 76:5062–5070
Scarselli E, Cerino A, Esposito G et al (1995) Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients. J Virol 69:4407–4412
Schirren CA, Jung MC, Gerlach JT et al (2000) Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma. Hepatology 32:597–603
Schulze zur Wiesch J, Lauer JM, Day CL et al (2005) Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes. J Immunol 175:3603–3613
Scognamiglio P, Accapezzato D, Casciaro MA et al (1999) Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors. J Immunol 162:6681–6689
Semmo N, Klenerman P (2007) CD4+ T cell responses in hepatitis C virus infection. World J Gastroenterol 13:4831–4838
Semmo N, Krashias G, Willberg C et al (2007) Analysis of the relationship between cytokine secretion and proliferative capacity in hepatitis C virus infection. J Viral Hepat 14:492–502
Shedlock DJ, Shen H (2003) Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300:337–339
Shoukry NH, Grakoui A, Houghton M et al (2003) Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J Exp Med 197:1645–1655
Söderholm J, Ahlén G, Kaul A et al (2006) Relation between viral fitness and immune escape within the hepatitis C virus protease. Gut 55:266–274
Spada E, Mele A, Berton A et al (2004) Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance. Gut 53:1673–1681
Strickland GT, El-Kamary SS, Klenerman P et al (2008) Hepatitis C vaccine: supply and demand. Lancet Infect Dis 8:379–386
Sun JC, Williams MA, Bevan MJ (2004) CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection. Nat Immunol 5:927–933
Syriopoulou V, Nikolopoulou G, Daikos GL et al (2005) Mother to child transmission of hepatitis C virus: rate of infection and risk factors. Scand J Infect Dis 37:350–353
Takaki A, Wiese M, Maertens G et al (2000) Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 6:578–582
Tatsumi T, Takehara T, Miyagi T et al (2011) Hepatitis C virus-specific CD8+ T cell frequencies are associated with the responses of pegylated interferon-alpha and ribavirin combination therapy in patients with chronic hepatitis C virus infection. Hepatol Res 41:30–38
Tester I, Smyk-Pearson S, Wang P et al (2005) Immune evasion versus recovery after acute hepatitis C virus infection from a shared source. J Exp Med 201:1725–1731
Thimme R, Oldach D, Chang KM et al (2001) Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 194:1395–1406
Thomson EC, Nastouli E, Main J (2009) Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV. AIDS 23:89–93
Thursz M, Yallop R, Goldin R et al (1999) Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research. Lancet 354:2119–2124
Timm J, Lauer GM, Kavanagh DG et al (2004) CD8 epitope escape and reversion in acute HCV infection. J Exp Med 200:1593–1604
Ulsenheimer A, Gerlach JT, Gruener NH et al (2003) Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Hepatology 37:1189–1198
Urbani S, Amadei B, Fisicaro P et al (2006) Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses. Hepatology 44:126–139
Waggoner SN, Hall CH, Hahn YS (2007) HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL-12 production. J Leukocyte Biol 82:1407–1419
Wedemeyer H, He XS, Nascimbeni M et al (2002) Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 169:3447–3458
Weiner Paliard X, Selby MJAJ et al (2001) Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity. J Virol 75:7142–7148
Welsh RM, Selin LK (2002) No one is naive: the significance of heterologous T-cell immunity. Nat Rev Immunol 2:417–426
Yi JS, Cox MA, Zajac AJ (2010) T-cell exhaustion: characteristics, causes and conversion. Immunology 129:474–481
Zeremski M, Shu MA, Brown Q et al (2009) Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users. J Viral Hepat 16:10–20
Zhang X, Dou J, Germann MW (2009) Characterization of the cellular immune response in hepatitis C virus infection. Med Res Rev 29:843–866
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors of this article declare that they do not have any competing interests to the presented work.
About this article
Cite this article
Kaźmierczak, J., Caraballo Cortes, K., Bukowska-Ośko, I. et al. Virus-Specific Cellular Response in Hepatitis C Virus Infection. Arch. Immunol. Ther. Exp. 64, 101–110 (2016). https://doi.org/10.1007/s00005-015-0364-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00005-015-0364-8